Back to search

Total Citations Per Year

Abstract

References (52)

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

1992 • 1,582 citations

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1998 • 1,575 citations

Diagnosis and Treatment of Alzheimer Disease and Related Disorders

1997 • 925 citations

Multiattribute Utility Function for a Comprehensive Health Status Classification System

1996 • 880 citations

Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>

1998 • 753 citations

The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial

1996 • 730 citations

The US economic and social costs of Alzheimer's disease revisited.

1994 • 600 citations

The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial<sup>1</sup>

1999 • 581 citations

Cholinesterase Inhibitors in the Treatment of Alzheimer??s Disease

1998 • 369 citations

Canadian study of health and aging: study methods and prevalence of dementia.

1994 • 318 citations

Long-term tacrine (Cognex) treatment

1996 • 300 citations

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

1998 • 289 citations

Alzheimer's Disease Care: Costs And Potential Savings

1998 • 252 citations

Relation between severity of Alzheimer's disease and costs of caring.

1998 • 238 citations

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease

1999 • 236 citations

Economic Considerations in Alzheimer's Disease

1998 • 197 citations

Cognitive Function and the Costs of Alzheimer Disease

1997 • 173 citations

Tacrine

1994 • 139 citations

Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada

1999 • 126 citations

Donepezil Use in Alzheimer Disease

1998 • 126 citations

Donepezil

1997 • 120 citations

Alzheimer's disease: the burden of the illness in England.

1993 • 118 citations

Donepezil: an anticholinesterase inhibitor for Alzheimer’s disease

1997 • 104 citations

Economic impact of Alzheimer's disease in the United Kingdom

1999 • 99 citations

An economic evaluation of donepezil in the treatment of Alzheimer's disease

1998 • 95 citations

Pharmacotherapy for people with Alzheimer's disease: a Markov-cycle evaluation of five years' therapy using donepezil

1998 • 92 citations

Guidelines on drug treatments for Alzheimer's disease

1997 • 80 citations

Recent Developments in the Drug Treatment of Alzheimer??s Disease

1999 • 74 citations

Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association [published erratum appears in Am J Psychiatry 1997 Aug;154(8):1180]

1997 • 64 citations

The economic impact of tacrine in the treatment of Alzheimer's disease

1997 • 59 citations

The perspective of the person with Alzheimer disease: which outcomes matter in early to middle stages of dementia?

1997 • 55 citations

Emerging Antidementia Drugs: A Preliminary Ethical View

1998 • 48 citations

Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

1997 • 45 citations

Epidemiology of Alzheimer's disease.

1997 • 45 citations

An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer??s Disease

1998 • 45 citations

Treatment of Alzheimer disease with tacrine: a cost-analysis model.

1997 • 42 citations

The Cost of Alzheimerʼs Disease

1996 • 40 citations

First International Pharmacoeconomic Conference on Alzheimerʼs Disease: Report and Summary

1998 • 31 citations

Drug Treatment of Alzheimerʼs Disease

1996 • 29 citations

Guidelines for the Appropriate Use of Cholinesterase Inhibitors in Patients with Alzheimer??s Disease

1999 • 28 citations

A Review of Quality of Life in Alzheimer??s Disease

1998 • 27 citations

Pharmacoeconomic Models in Disease Management

1998 • 22 citations

Methods of cost-effectiveness analysis in the assessment of new drugs for Alzheimer's disease

1997 • 19 citations

Drug Treatments for Alzheimer??s Disease

1999 • 19 citations

Donepezil (Aricept) therapy for Alzheimer's disease.

1997 • 19 citations

Epidemiology of dementias

1998 • 17 citations

Cholinesterase Inhibitors in Alzheimer??s Disease

1999 • 16 citations

Beyond Tacrine

1998 • 14 citations

The Pharmacoeconomics of Dementia Therapies

1997 • 14 citations

Measuring Outcomes in Alzheimer??s Disease Research

1999 • 9 citations

Which outcomes matter in Alzheimer disease and who should define them?

1997 • 8 citations

Donepezil update.

1998 • 2 citations

Cited By (0)

Loading...